February 27, 2015 9:18 PM ET

Biotechnology

Company Overview of Kylin Therapeutics, Inc.

Company Overview

Kylin Therapeutics, Inc., a biotechnology company, develops and delivers RNA interference (RNAi) based therapeutics in the United States. It offers pRNA, a RNA-based nanoparticle system to treat cancer, HIV, and other diseases. The company was founded in 2006 and is based in West Lafayette, Indiana.

3000 Kent Avenue

West Lafayette, IN 47906

United States

Founded in 2006

Phone:

765-269-8030

Key Executives for Kylin Therapeutics, Inc.

Chief Executive Officer, President and Director
Founder and Chairman of the Scientific Advisory Board
Director of Technology Development
Director of Research and Development Team
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Glycotex, Inc. United States
Predictive Biomarker Sciences, Inc. United States
Kosan Biosciences Incorporated United States
RayBiotech, Inc. United States
NGM Biopharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kylin Therapeutics, Inc., please visit www.kylintherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.